Caseload and In-Hospital Outcome of Carotid Surgery Performed during the COVID-19 Pandemic vs. Previous Years: A Single-Centre Analysis

Abstract

Introduction

With the beginning of the COVID-19 pandemic in March 2020, restrictions and challenges for elective and emergency vascular surgery as well as worse outcomes were reported. This study aims to compare our single-centre experience with carotid artery surgery during the pandemic and previous years.

Methods

Our retrospective analysis included all consecutive patients undergoing carotid surgery for symptomatic and asymptomatic stenosis between January 2017 and December 2021. Caseload, operation specific parameters, and demographic data as well as in-hospital outcome were compared during the COVID-19 pandemic versus previous years.

Results

A total of 623 consecutive patients were included. The caseload comparison showed an average of 112 carotid artery surgeries per adjusted year (March 16th to December 31st) from 2017 to 2019, prior to the pandemic. The caseload reduction in the first year of the pandemic (2020) was 36.6% (n = 71) and 17.9% (n = 92) in the second year (2021). No rebound effect was observed. There was no significant difference (p = 0.42) in the allocation of symptomatic and asymptomatic patients (asymptomatic patients: 37.1% prior vs. 40.8% during the pandemic; symptomatic patients: 62.9 vs. 59.2%). Major adverse event rates in years prior to the pandemic were postoperative bleeding requiring revision: n = 31 (7.1%); stroke in symptomatic patients: n = 9 (3.3%) and stroke in asymptomatic patients: n = 4 (2.5%); symptomatic myocardial infarction (MCI): n = 1 (0.2%); death: n = 2 (0.5%). During the pandemic, major adverse event rates were postoperative bleeding requiring revision: n = 12 (6.5%); stroke in symptomatic patients: n = 1 (0.9%), stroke in asymptomatic patients: n = 1 (1.3%); symptomatic MCI: n = 1 (0.5%); death: n = 1 (0.5%).

Conclusion

Since the beginning of the COVID-19 pandemic in March 2020, there has been a significant reduction in carotid artery surgery performed both in symptomatic as well as in asymptomatic patients. There was no worsening of the outcome of carotid surgery performed during the COVID-19 pandemic, and this remained safe and feasible.

Zusammenfassung

Einführung

Mit Beginn der COVID-19-Pandemie im März 2020 wurden Einschränkungen und Herausforderungen für elektive und notfallmäßige Gefäßoperationen sowie eine Verschlechterung der Ergebnisse gemeldet. Diese Studie zielt darauf ab, unsere Single-Center-Erfahrungen während der Pandemie und in früheren Jahren zu vergleichen.

Material und Methoden

Unsere retrospektive Analyse umfasste alle Patient*innen, die sich zwischen Januar 2017 und Dezember 2021 einer Karotisoperation wegen symptomatischer und asymptomatischer Stenose unterzogen. Die Fallzahl, operationsspezifische Parameter und demografische Daten sowie das Ergebnis im Krankenhaus wurden während der COVID-19-Pandemie mit den Vorjahren verglichen.

Ergebnisse

Insgesamt wurden 623 Patient*innen eingeschlossen. Der Fallzahlenvergleich ergab einen Durchschnitt von 112 Halsschlagaderoperationen pro angepasstem Jahr (16. März bis 31. Dezember) von 2017 bis 2019 vor der Pandemie. Die Fallzahlreduktion betrug im 1. Jahr der Pandemie (2020) 36,6% (n = 71) und im 2. Jahr (2021) 17,9% (n = 92). Es wurde kein Rebound-Effekt beobachtet. Es gab keinen signifikanten Unterschied (p = 0,42) bei der Verteilung von symptomatischen und asymptomatischen Patient*innen (asymptomatische Patient*innen: 37,1% vor vs. 40,8% während der Pandemie; symptomatische Patient*innen: 62,9% vs. 59,2%). Die Raten schwerwiegender unerwünschter Komplikationen in den Jahren vor der Pandemie waren: postoperative Blutungen, die eine Revision erforderten: n = 31 (7,1%); Schlaganfall bei symptomatischen Patienten: n = 9 (3,3%) und Schlaganfall bei asymptomatischen Patienten: n = 4 (2,5%); symptomatischer Myokardinfarkt (MCI): n = 1 (0,2%); Tod: n = 2 (0,5%). Während der Pandemie kam es zu folgenden schwerwiegenden unerwünschten Komplikationen: postoperative Blutungen, die eine Revision erforderten: n = 12 (6,5%); Schlaganfall bei symptomatischen Patient*innen: n = 1 (0,9%), Schlaganfall bei asymptomatischen Patient*innen: n = 1 (1,3%); symptomatischer MCI: n = 1 (0,5%); Tod: n = 1 (0,5%).

Schlussfolgerung

Seit Beginn der COVID-19-Pandemie im März 2020 kam es zu einem deutlichen Rückgang der durchgeführten Halsschlagaderoperationen, sowohl bei symptomatischen als auch bei asymptomatischen Patient*innen. In unserem Zentrum kam es zu keiner Verschlechterung der Ergebnisse während der COVID-19-Pandemie durchgeführten Karotisoperationen und verblieben somit sicher durchführbar.

Keywords

stenosis of the carotid artery - case load - endarteriectomy - COVID

Schlüsselwörter

Karotisstenose - Karotisdesobliteration - OP-Frequenz - Case Load - COVID

Publication History

Received: 26 March 2024

Accepted after revision: 29 August 2024

Article published online:
18 September 2024

• References

• 1 Klocker J, Frech A, Gratl A. et al. Operieren, Absagen, Verschieben oder Selektionieren? Ergebnisse einer Umfrage unter gefäßchirurgischen Zentren während der Covid-19-Krise in Österreich. Gefässchirurgie 2020; 25: 417-422
• 2 Ball S, Banerjee A, Berry C. et al. Monitoring indirect impact of COVID-19 pandemic on services for cardiovascular diseases in the UK. Heart 2020; 106: 1890-1897
• 3 Piazza M, Xodo A, Squizzato F. et al. The challenge of maintaining necessary vascular and endovascular services at a referral center in Northern Italy during the COVID-19 outbreak. Vascular 2021; 29: 477-485
• 4 Cai TY, Fisher G, Loa J. Changing patterns in Australian and New Zealand: vascular surgery during COVID-19. ANZ J Surg 2021; 91: 2389-2396
• 5 Crespy V, Benzenine E, Mariet AS. et al. Impact of the first COVID-19 pandemic peak and lockdown on the interventional management of carotid artery stenosis in France. J Vasc Surg 2022; 75
• 6 Cancer-Perez S, Alfayate-García J, Vicente-Jiménez S. et al. Symptomatic Common Carotid Free-Floating Thrombus in a COVID-19 Patient, Case Report and Literature Review. Ann Vasc Surg 2021; 73: 122-128
• 7 Esenwa C, Cheng NT, Lipsitz E. et al. COVID-19-Associated Carotid Atherothrombosis and Stroke. AJNR Am J Neuroradiol 2020; 41: 1993-1995
• 8 Benson RA, Nandhra S. Outcomes of Vascular and Endovascular Interventions Performed During the Coronavirus Disease 2019 (COVID-19) Pandemic. Ann Surg 2021; 273: 630-635
• 9 Qureshi AI, Agunbiade S, Huang W. et al. Changes in Neuroendovascular Procedural Volume During the COVID-19 Pandemic: An International Multicenter Study. J Neuroimaging 2021; 31: 171-179
• 10 Mesnier J, Cottin Y, Coste P. et al. Hospital admissions for acute myocardial infarction before and after lockdown according to regional prevalence of COVID-19 and patient profile in France: a registry study. Lancet Public Health 2020; 5: e536-e542
• 11 Mariet A-S, Giroud M, Benzenine E. et al. Hospitalizations for Stroke in France During the COVID-19 Pandemic Before, During, and After the National Lockdown. Stroke 2021; 52: 1362-1369
• 12 Krafcik BM, Gladders B, Jarmel I. et al. The Sustained Impact of the COVID-19 Pandemic on Vascular Surgical Care Delivery. Ann Vasc Surg 2024; 108: 26-35
• 13 Barnett HJM, Taylor DW, Haynes RB. North American Symptomatic Carotid Endarterectomy Trial Collaborators. et al. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 1991; 325: 445-453
• 14 Halliday A, Bulbulia R, Bonati LH. et al. Second asymptomatic carotid surgery trial (ACST-2): a randomised comparison of carotid artery stenting versus carotid endarterectomy. Lancet 2021; 398: 1065-1073
• 15 Gomez-Arbelaez D, Ibarra-Sanchez G, Garcia-Gutierrez A. et al. COVID-19-related aortic thrombosis: a report of four cases. Ann Vasc Surg 2020; 67: 10-13
• 16 Indes JE, Koleilat I, Hatch AN. J Vasc Surg. et al. Early experience with arterial thromboembolic complications in patients with COVID-19. 2021; 73: 381-389.e1
• 17 Viguier A, Delamarre L, Duplantier J. et al. Acute ischemic stroke complicating common carotid artery thrombosis during a severe COVID-19 infection. J Neuroradiol 2020; 47: 393-394
• 18 Doo FX, Kassim G, Lefton DR. et al. Rare presentations of COVID-19: PRES-like leukoencephalopathy and carotid thrombosis. Clin Imaging 2021; 69: 94-101
• 19 Fara MG, Stein LK, Skliut M. et al. Macrothrombosis and stroke in patients with mild Covid-19 infection. J Thromb Haemost 2020; 18: 2031-2033
• 20 Gulko E, Gomes W, Ali S. et al. Acute common carotid artery bifurcation thrombus: an emerging pattern of acute strokes in patients with COVID-19?. AJNR Am J Neuroradiol 2020; 41: E65-E66
• 21 Mohamud AY, Griffith B, Rehman M. et al. Intraluminal carotid artery thrombus in COVID-19: another danger of cytokine storm?. AJNR Am J Neuroradiol 2020; 41: 1677-1682
• 22 Mowla A, Sizdahkhani S, Sharifian-Dorche M. et al. Unusual pattern of arterial macrothrombosis causing stroke in a young adult recovered from COVID-19. J Stroke Cerebrovasc Dis 2020; 29: 105353
• 23 Hosseini M, Sahajwani S, Zhang J. et al. Delayed stroke after hospitalization for coronavirus disease 2019 pneumonia from common and internal carotid artery thrombosis. J Vasc Surg Cases Innov Tech 2021; 7: 40-45
• 24 Lapergue B, Lyoubi A, Meseguer E. et al. Large vessel stroke in six patients following SARS-CoV-2 infection: a retrospective case study series of acute thrombotic complications on stable underlying atherosclerotic disease. Eur J Neurol 2020; 27: 2308-2311
• 25 Alkhaibary A, Abbas M, Ahmed ME. et al. Common carotid artery occlusion in a young patient: can large-vessel stroke be the initial clinical manifestation of coronavirus disease 2019?. World Neurosurg 2020; 144: 140-142